Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development.

Biotechnology

Aristea Therapeutics

Aristea Therapeutics' headquarters in San Diego, CA, United States

James Mackay

Deanne Reid

Nihar Bhakta

Daniel O’Connell

Tyrell Rivers

Michael S. Vincent

Kenneth Harrison

Loretta Tse

The Directors team at Aristea Therapeutics consists of seasoned leaders overseeing various critical functions, including clinical operations, regulatory and quality affairs, and business development. This team is responsible for driving strategic initiatives, ensuring compliance with industry standards, and facilitating the successful development and advancement of the company's novel therapies for inflammatory diseases.

Directors

The Leadership Team at Aristea Therapeutics is responsible for guiding the strategic vision and direction of the company. This team, composed of key executives such as the President & CEO and Chief Medical Officers, oversees drug development initiatives, fosters partnerships, and ensures alignment with the company's goals to bring innovative therapies for inflammatory diseases to market, including the advancement of RIST4721 through Phase 2 clinical trials.

Aristea Therapeutics

Org chart

Board & advisors

Teams

Directors

Leadership Team

Offices

Aristea Therapeutics

Org chart

Board & advisors

Teams

Directors

Leadership Team

Offices

Related companies